<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Leap Therapeutics, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Leap Therapeutics, Inc.

    Leap Therapeutics (NASDAQ: LPTX) is focused on developing targeted and immuno-oncology therapeutics. Leap's most advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein, a Wnt pathway modulator. DKN-01 is in clinical trials in patients with esophagogastric, hepatobiliary, gynecologic, and prostate cancers. Leap's second clinical candidate, TRX518, is a humanized GITR agonist monoclonal antibody designed to enhance the immune system's anti-tumor response that is in advanced solid tumor studies. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Chris Mirabelli, Ph.D.
    • FOUNDED
      2011
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    ADiTx Therapeutics, Inc

    ADiTx Therapeutics, Inc

    The discovery of immunosuppressive (anti-rejection) drugs has made possible life-s...

    The discovery of immunosuppressive (anti-reject...

    Filing Type:    RA
    Incyte Corporation

    Incyte Corporation

    Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focus...

    Incyte Corporation is a Wilmington, Delaware-ba...

    Filing Type:    PU
    American International Holdings Corp.

    American International Holdings Corp.

    American International Industries, Inc. (OTCQB: AMIN) is a diversified holding com...

    American International Industries, Inc. (OTCQB:...

    Filing Type:    RA
    Allakos Inc.

    Allakos Inc.

    Allakos is a clinical-stage company developing therapeutic antibodies that selecti...

    Allakos is a clinical-stage company developing ...

    Filing Type:    PU
    ICON plc

    ICON plc

    Since our foundation in Dublin, Ireland in 1990, our mission has been to help our ...

    Since our foundation in Dublin, Ireland in 1990...

    Filing Type:    PU
    China SXT Pharmaceuticals, Inc.

    China SXT Pharmaceuticals, Inc.

    China SXT Pharmaceuticals, Inc. is an innovative pharmaceutical company based in T...

    China SXT Pharmaceuticals, Inc. is an innovativ...

    Filing Type:    PU
    Clovis Oncology, Inc.

    Clovis Oncology, Inc.

    Founded in 2009, Clovis Oncology (NASDAQ: CLVS) is a commercial stage biotechnolog...

    Founded in 2009, Clovis Oncology (NASDAQ: CLVS)...

    Filing Type:    PU
    CohBar, Inc.

    CohBar, Inc.

    CohBar, Inc. is a leader in the research and development of mitochondria based the...

    CohBar, Inc. is a leader in the research and de...

    Filing Type:    PU
    Genomic Health, Inc.

    Genomic Health, Inc.

    Genomic Health, Inc. (NASDAQ: GHDX) is the world's leading provider of genomic-bas...

    Genomic Health, Inc. (NASDAQ: GHDX) is the worl...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.